Medical News

RSS

New tool can measure cardiovascular risk in persons aged 40 or older

For the first time, scientists have developed a new risk score that can predict the 10-year risk of developing heart disease or having a stroke in persons aged 40 years or older in any world country.

27 Mar 2015

New report explores global issues affecting confidence, hesitation about polio vaccines

A decade on from the Northern Nigeria polio vaccination boycott and its global costs to the polio eradication initiative, a new report examines global issues affecting confidence and hesitation about vaccines since the new millennium.

27 Mar 2015

3D respiratory tissue model shown to be effective for measuring impact of chemicals

A 3-dimensional model of human respiratory tissue has been shown to be an effective platform for measuring the impact of chemicals, like those found in cigarette smoke, or other aerosols on the lung.

27 Mar 2015

Study sheds light on cataract development

The motion of coins in a "Penny Pusher" carnival game is similar to the movement of cells in the eye's lens, as described in a new study published in Investigative Ophthalmology & Visual Science (IOVS).

27 Mar 2015

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced the launch and first commercial use of an updated SImmetry Sacroiliac Joint Fusion System. The surgery was performed by Dr. Brett Menmuir.

27 Mar 2015

Study: 70% of nurses in Scotland lack confidence in new delayed discharge target in hospitals

As the Scottish Government prepares to introduce a new two-week discharge target in hospitals from 1st April 2015, a new study has found 70 per cent of nurses in Scotland lack confidence in the policy and do not believe it will help reduce delays.

27 Mar 2015

Taconic, Cellaria partner to facilitate use of patient-derived xenografts for oncology research

Taconic Biosciences and Cellaria Biosciences today announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s novel methodologies for generating cells from patient tumors will complement Taconic’s industry-leading portfolio of tissue humanized mouse models, which are well-suited as hosts for PDXs.

27 Mar 2015

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

apceth, a global leader in engineered cell therapies, today announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich.

27 Mar 2015

NHS England launches online directory to support people with mental health conditions

Yesterday, the new NHS Choices Mental Health Apps Library was launched to the public. Big White Wall was among the first five mental health services to be featured in this online directory.

27 Mar 2015

Research reveals why people with type 1 diabetes are unable to control blood glucose levels

TEACHING people with type 1 diabetes how to embed lifelong habits such as carbohydrate counting into everyday life rather than as part of week-long education programmes could significantly reduce their risk of complications from the disease, according to new research.

27 Mar 2015

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies’ ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs.

27 Mar 2015

DePuy Synthes adds four new products to adult deformity portfolio

DePuy Synthes Companies announced the addition of four new products to its adult deformity portfolio as well as a new education offering, continuing its expansion of one of the broadest spine portfolios in the industry. The products were displayed by DePuy Synthes Spine at the 81st annual meeting of the American Academy of Orthopaedic Surgeons.

27 Mar 2015

Ebola more likely to be fatal for young children

Ebola progresses more quickly and is more likely to be fatal for children under five, according to new research. An international group of scientists led by Imperial College London and the World Health Organization analysed data on Ebola cases in children under 16 during the current outbreak in Guinea, Liberia and Sierra Leone, comparing them to cases in adults.

27 Mar 2015

Regeneron announces FDA approval of EYLEA (aflibercept) Injection for diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.

27 Mar 2015

TeleHealth Services, Samsung complete new SmarTigr system to improve patient-provider communication

TeleHealth Services, the nation’s leading provider of hospital televisions and interactive patient engagement solutions, announced through their partnership with Samsung Electronics America, Inc., the completion of a new patient engagement solution called SmarTigr.

27 Mar 2015

GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial

GENFIT, today announces topline results of the phase 2 GOLDEN-505 trial in NASH. Due to the unexpected rate of resolution of NASH in patients randomized to placebo who had early NASH (NAS of 3, placebo response rate>57%), along with the high number of sites for a limited sample size, the study as initially designed did not enable the trial to meet directly the primary endpoint.

27 Mar 2015

Minimally-invasive surgery offers long-term cost savings for healthcare system, less trauma for patients

Adding to the clinical benefits and improved patient outcomes associated with minimally-invasive surgery (MIS), Medtronic plc today highlighted new data demonstrating that patients who underwent minimally invasive colon resection procedures were able to leave the hospital faster, visit their doctors less for follow up care and take fewer medicines than those who underwent open surgery.

27 Mar 2015

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT assay) based on quantitative real-time PCR (qPCR). This NIPT assay, designed to determine fetal aneuploidies from maternal blood, will offer significant advantages, such as enhanced test performance at affordable prices, over other prenatal examination methods.

27 Mar 2015

WHO report: Access to new medicines requires transparency, collaboration

As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe.

27 Mar 2015

Updated guidelines for diagnosis, treatment of medullary thyroid carcinoma released

A Task Force convened by the American Thyroid Association released updated guidelines for the diagnosis and treatment of medullary thyroid carcinoma (MTC). The current document is the first revision of the original guidelines published in 2009.

26 Mar 2015

Medical News

New tool can measure cardiovascular risk in persons aged 40 or older

New report explores global issues affecting confidence, hesitation about polio vaccines

3D respiratory tissue model shown to be effective for measuring impact of chemicals

Study sheds light on cataract development

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Study: 70% of nurses in Scotland lack confidence in new delayed discharge target in hospitals

Taconic, Cellaria partner to facilitate use of patient-derived xenografts for oncology research

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

NHS England launches online directory to support people with mental health conditions

Research reveals why people with type 1 diabetes are unable to control blood glucose levels

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes adds four new products to adult deformity portfolio

Ebola more likely to be fatal for young children

Regeneron announces FDA approval of EYLEA (aflibercept) Injection for diabetic retinopathy

TeleHealth Services, Samsung complete new SmarTigr system to improve patient-provider communication

GFT505 demonstrates dose-dependent efficacy on primary endpoint in phase 2 NASH trial

Minimally-invasive surgery offers long-term cost savings for healthcare system, less trauma for patients

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

WHO report: Access to new medicines requires transparency, collaboration

Updated guidelines for diagnosis, treatment of medullary thyroid carcinoma released

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News